Skip to content

Benjamin Rolland

7 papers in the library · 139 citations · publishing 2014-2026

Papers

Sort Most recent Most cited

Impact of cannabis use and cannabis composition on formal thought disorder and related brain networks: An fMRI study in 51 patients with schizophrenia

Schizophrenia Research October 23, 2026 Thomas Bernabeu, Mathilde Argote, Antony Citterio‐Quentin et al.

BACKGROUND: Formal thought disorder (FTD) is a core dimension of schizophrenia, which has been associated in previous studies with increased brain functional connectivity between temporal gyri and striatal regions as measured with fMRI. Cannabis use is highly prevalent in schizophrenia population as compared with the general population and, in the context of elevated...

French psychiatric caregivers' perceptions of psychedelics: A national survey.

L'Encephale October 16, 2026 Anne Buot, Jean-Del Burdairon, Luc Mallet et al.

The use of psychedelic substances such as LSD, psilocybin, and dimethyltryptamine is currently being re-evaluated for their therapeutic potential in psychiatry. While international clinical research had started in the 2010s, France only initiated its first psychedelic trials in 2024. This study aimed to explore the knowledge, perceptions, and attitudes of French mental health professionals...

Addressing the Global Challenge of Nitrous Oxide Misuse Through a Multidisciplinary Approach: Example of the PROTOSIDE Network

Toxics May 31, 2025 Guillaume Grzych, R. Diesnis, Thierry Dupré et al.

Nitrous oxide (N2O) was originally used for medical and industrial purposes, but its recreational use has dramatically increased, raising a major global public health concern. Chronic inhalation is associated with neurological, metabolic, and psychiatric complications, as well as addiction. To address these challenges, the PROTOSIDE network was developed to provide a multidisciplinary approach...

Impact of psychedelics on craving in addiction: A systematic review.

Journal of Psychopharmacology February 1, 2025 Sophie-Athéna Chapron, Guilhem Bonazzi, Laura Di Lodovico et al. 5 citations

In the context of the need to increase treatment options for substance use disorders, recent research has evaluated the therapeutic potential of psychedelics. However, there is an incomplete understanding of psychedelics' effects on craving, a core symptom of addictive disorders and a predictor of substance use and relapse. To determine if the use of psychedelics is associated with changes in...

Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals

EClinicalMedicine September 8, 2023 Mathilde Argote, Guillaume Sescousse, Jérôme Brunelin et al. 31 citations

Background: The association between cannabis use and positive symptoms in schizophrenia spectrum disorders is well documented, especially via meta-analyses. Yet, findings are inconsistent regarding negative symptoms, while other dimensions such as disorganization, depression, and excitement, have not been investigated. In addition, meta-analyses use aggregated data discarding important...

Association between formal thought disorder and cannabis use: a systematic review and meta-analysis

Schizophrenia September 29, 2022 Mathilde Argote, Guillaume Sescousse, Jérôme Brunelin et al. 7 citations

Formal thought disorder (FTD) is a multidimensional syndrome mainly occurring along the psychosis continuum. Cannabis use is known to increase symptoms of psychosis, particularly positive symptoms. However, the impact of cannabis use on FTD in individuals presenting symptoms along the psychosis continuum remains unclear. To address this knowledge gap, we conducted a meta-analysis examining the...

Pharmacology of Hallucinations: Several Mechanisms for One Single Symptom?

BioMed Research International 2014 Benjamin Rolland, Renaud Jardri, Ali Amad et al. 96 citations

Hallucinations are complex misperceptions, that principally occur in schizophrenia or after intoxication induced by three main classes of drugs: psychostimulants, psychedelics, and dissociative anesthetics. There are at least three different pharmacological ways to induce hallucinations: (1) activation of dopamine D2 receptors (D2Rs) with psychostimulants, (2) activation of serotonin 5HT2A...

DOI: 10.1155/2014/307106 (opens in new tab) Full text (opens in new tab) Hallucinogen Psychosis Schizophrenia object-oriented programming Dissociative +4